(GMED)
0.00
0.00 (0.00%)

0.00
0.00 (0.00%)
This stock has a consensus price target of $99.00 based on the ratings of 18 analysts. The high is $123.00 and the low is $64.00.
| Target | Lowest Price Target | Consensus Price Target | Highest Price Target |
|---|---|---|---|
| Price | $ 64 | $ 99 | $ 123 |
| Change | -23.61% | 18.17% | 46.81% |
| Date | Upside/Downside | Analyst Firm | Price Target | Rating Change | Rating |
|---|---|---|---|---|---|
| 2026-02-26 | 24.13% | Wells Fargo | $98 → $104 | Maintains | Overweight |
| 2026-02-25 | 46.81% | Barclays | $118 → $123 | Maintains | Overweight |
| 2026-02-25 | 36.07% | Needham | $112 → $114 | Maintains | Buy |
| 2026-01-30 | 33.68% | Needham | $112 | Upgrades | Hold → Buy |
| 2026-01-09 | 33.68% | Canaccord Genuity | $105 → $112 | Maintains | Buy |